<DOC>
	<DOCNO>NCT01410903</DOCNO>
	<brief_summary>The purpose study evaluate source data survival investigation preliminary efficacy immunoadsorption patient severe systemic sclerosis .</brief_summary>
	<brief_title>Immunoadsorption Patients With Severe Systemic Sclerosis</brief_title>
	<detailed_description />
	<mesh_term>Sclerosis</mesh_term>
	<mesh_term>Scleroderma , Systemic</mesh_term>
	<mesh_term>Scleroderma , Diffuse</mesh_term>
	<criteria>systemic sclerosis accord ACEcriteria severe pulmonary manifestation reduce DLCO sign informed consent inadequate peripheral venous access participation another clinical trial heart failure pronounce allergic diathesis , particularly case know hypersensitivity drug and/or material use extracorporeal circuit</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>August 2015</verification_date>
</DOC>